Insiders · VVOS

VVOS insider transactions

Vivos Therapeutics Inc. (VVOS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

VVOS insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Vivos Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Leonard J SokolowDirector
• Gregg C JohnsonDirector, since February 2026
• Ronald Kirk HuntsmanChief Executive Officer, Director, since December 2020+$112K
• Bradford K. AmmanPrincipal Accounting Officer+$5,290
• Michael C Skaff10% owner, since June 2025+$1.81M
• V-Co Investors 4 LLC10% owner, since June 2026
• V-Co Investors 3 LLC10% owner, since March 2026
• Matthew ThompsonDirector
• Mark F. LindsayDirector
• Anja B KrammerDirector
• Ralph Elias GreenDirector
• Gurdev Dave SinghOfficer, Director, 10% owner

Recent Form 3, 4, and 5 filings for VVOS

• 12d
  SEC Form 4 filed by Vivos Therapeutics Inc.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 13d
  SEC Form 4 filed by Vivos Therapeutics Inc.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 13d
  SEC Form 4 filed by Vivos Therapeutics Inc.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 51d
  SEC Form 4 filed by Director Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 51d
  SEC Form 4 filed by Director Johnson Gregg C

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 51d
  Chief Executive Officer Huntsman Ronald Kirk acquired $50,000 worth of Preferred Stock (85,910 units at $0.58) (SEC Form 4)

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 74d
  Principal Accounting Officer Amman Bradford K. was granted 250,000 shares, increasing direct ownership by 312,500% to 250,080 units (SEC Form 4)

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 116d
  SEC Form 4 filed by Large owner Skaff Michael C

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 116d
  SEC Form 3 filed by new insider V-Co Investors 4 Llc

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 212d
  SEC Form 3 filed by new insider V-Co Investors 3 Llc

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 220d
  SEC Form 4 filed by Skaff Michael C

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 268d
  New insider Johnson Gregg C claimed ownership of 3,997 shares (SEC Form 3)

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 506d
  New insider Skaff Michael C claimed ownership of 1,342,498 shares (SEC Form 3)

  3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 711d
  SEC Form 4 filed by Chief Executive Officer Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 711d
  SEC Form 4 filed by Chief Financial Officer Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Director Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Director Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Chief Executive Officer Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Director Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Director Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Director Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 863d
  SEC Form 4 filed by Chief Financial Officer Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1237d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1237d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1242d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4: Huntsman Ronald Kirk bought $10,000 worth of shares (20,000 units at $0.50), increasing direct ownership by 73% to 47,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4 filed by Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4 filed by Sokolow Leonard J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4 filed by Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4 filed by Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1411d
  SEC Form 4 filed by Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1619d
  SEC Form 4: Huntsman Ronald Kirk bought $23,560 worth of shares (12,000 units at $1.96), increasing direct ownership by 77% to 27,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1714d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1714d
  SEC Form 4 filed by Huntsman Ronald Kirk

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1728d
  SEC Form 5 filed by Huntsman Ronald Kirk

  5 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1873d
  SEC Form 4: Huntsman Ronald Kirk bought $21,550 worth of Common Stock (5,000 units at $4.31), increasing direct ownership by 48% to 15,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1893d
  SEC Form 4 filed by Amman Bradford K.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1908d
  SEC Form 4: Huntsman Ronald Kirk bought $15,000 worth of Common Stock (5,000 units at $3.00), increasing direct ownership by 91% to 10,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1916d
  SEC Form 4 filed by Singh Gurdev Dave

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1916d
  SEC Form 4 filed by Krammer Anja B

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1916d
  SEC Form 4 filed by Green Ralph Elias

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1916d
  SEC Form 4 filed by Thompson Matthew

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1916d
  SEC Form 4 filed by SOKOLOW LEONARD J

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1916d
  SEC Form 4 filed by Lindsay Mark F.

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1958d
  SEC Form 3: Huntsman Ronald Kirk claimed ownership of 1,740,000 units of Common Stock (Amendment)

  3/A - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1993d
  SEC Form 4: Huntsman Ronald Kirk bought $21,520 worth of Common Stock (4,000 units at $5.38), increasing direct ownership by 267% to 5,500 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 1993d
  SEC Form 4: Amman Bradford K. bought $5,290 worth of Common Stock (1,000 units at $5.29), increasing direct ownership by 100% to 2,000 units

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)
• 2062d
  SEC Form 4 filed by K. Bradford Amman

  4 - Vivos Therapeutics, Inc. (0001716166) (Issuer)